Autism has a strong genetic background with a higher frequency of affected males suggesting involvement of X-linked genes and possibly also other factors causing the unbalanced sex ratio in the etiology of the disorder. We have identified two missense mutations in the ribosomal protein gene RPL10 located in Xq28 in two independent families with autism. We have obtained evidence that the amino-acid substitutions L206M and H213Q at the C-terminal end of RPL10 confer hypomorphism with respect to the regulation of the translation process while keeping the basic translation functions intact. This suggests the contribution of a novel, possibly modulating aberrant cellular function operative in autism. Previously, we detected high expression of RPL10 by RNA in situ hybridization in mouse hippocampus, a constituent of the brain limbic system known to be afflicted in autism. Based on these findings, we present a model for autistic disorder where a change in translational function is suggested to impact on those cognitive functions that are mediated through the limbic system.
Introduction
Autism is the prototypical pervasive developmental disorder and is characterized by marked social deficits, deviant language and a restricted range of stereotyped repetitive behaviors. These symptoms usually occur within the first three years of life. 1 Autism is a distinct neurodevelopmental syndrome with lifelong persistence and is caused mainly by genetic factors with at least three to four genes, and possibly up to 100 genes, involved but with little environmental influences. 1, 2 Syndrome pathogenesis is associated with abnormal brain development and manifest in several specific brain regions, especially cerebellum, amygdala and hippocampus. 1, 3, 4 The prevalence of autism is at least 10-30/10 000 5 with a ratio of male to female affected individuals of approximately 4:1 6 implying involvement of X-chromosomal genetic factors and imprinting effects being responsible for the unbalanced sex distribution. Four of currently 12 genome screens have shown linkage with markers in Xp22.3 and Xq13-q26. [7] [8] [9] [10] Recently, more detailed analysis including additional markers revealed positive linkage findings in Xq27-q28. 11 We conducted a systematic screen involving all so far uncharacterized genes in Xq28 to gain insights into functional aspects of the encoded gene products. 12 The developmental and tissue-specific expression observed for several genes pointed towards candidates for Xq28-linked diseases with symptoms of mental retardation. Although autism differs from individuals with mental retardation alone by unusual psychometric profiles, 13 it is often associated with mental retardation. Therefore, we conducted a mutation screen in a primary set of four candidate genes (STK23, HCFC1, RPL10, ATP6AP1) in our sample of well-characterized patients with autistic disorder and mental retardation status (N = 27). A mutation in one of these patients has been detected in the ribosomal protein L10 gene (RPL10; formerly known as QM gene), whereas none have been evident in the other three genes under study. RPL10 is located approximately 1.2 Mb distal to the recent linkage locus for autism in Xq28. 11 On Northern blots, RPL10 appeared to be ubiquitously expressed. 12 Specific RNA in situ hybridization in mouse revealed regional enhanced expression in the CA3 region and granular layer of the dentate gyrus in the hippocampal formation, as well as in cortex, olfactory bulb, choroid plexus, testis, epididymis and uterus. 12 RPL10 belongs to the L10e family of ribosomal proteins highly conserved from human to yeast (221 amino-acid (aa); 65% protein identity compared to the human sequence) and archaea (174 aa; 43%). The L10e family members are the structural and functional orthologs of the L16 family in Eubacteria. RPL10 is a component of the 60S large ribosomal subunit, which assembles with the small 40S subunit to the 80S ribosome. In mammals, the 80S ribosomal nucleoprotein complex consists of four rRNAs and 79 proteins. The small 40S subunit mediates the interaction between tRNAs and the mRNA and selects for the correct tRNA in the decoding center. The large 60S subunit harbors the peptidyl transferase center and provides the exit tunnel for the growing nascent polypeptide chain. Structural data from yeast show that Rpl10 is located at the subunit interface side of the 60S subunit in a cleft between the central protuberance and the L7/L12 stalk near the A and P sites and close to the catalytic trans-peptidyl transferase center.
14 Experimental data from yeast indicate that Rpl10 is a multifunctional component of the large subunit that is successively involved in 60S preribosome assembly in the nucleolus, 15 and in the nuclear export of the 60S subunit. The latter is functionally linked to Nmd3 via the Xpo1/exportin export receptor pathway. 16, 17 Studies in yeast show that in the cytoplasm, Rpl10 is necessary for joining the 60S and 40S subunits in a late step of translation initiation, 18 a functional reflection of its location at the interface between the two ribosomal subunits adjoining the A and P sites as well as the transpeptidyl transferase center. The high level of sequence conservation of RPL10 in all organisms and the location close to regulatory and catalytic sites of the ribosome indicate the importance of the structural and functional integrity of this protein in ribosome assembly and function, respectively.
Here, we present two different missense mutations in the RPL10 gene found by screening the complete set of 345 patients with autistic disorder representing 296 independent families. Functional analysis in yeast suggests that the RPL10 missense mutations are still able to support basic translation functions, but fail to provide the cell with a functionally complete ribosome complement, that is they decrease the translational capacity of the cell.
Materials and methods

Patient and control sample
Patients with autistic disorder were recruited throughout Germany and Austria as previously described. 19 Affected individuals were assessed using the psychiatric instruments Autism Diagnostic Interview-Revised (ADI-R) 20 and Autism Diagnostic Observation Schedule (ADOS), 21 psychometric testing and routine molecular genetic screening to exclude the fragile X syndrome according to international guidelines. Following diagnosis the study group of 345 patients (268 males and 77 females) representing 296 independent families was subdivided into 317 patients with autistic disorder (including 27 patients with IQ < 35), 21 patients with Asperger syndrome, and seven patients with pervasive developmental disorder-not otherwise specified (PDD-NOS). A set of 263 unrelated Caucasian individuals (118 male and 145 female) of the same European ancestry as the patient sample has been available as a control group. Informed consent was obtained from all subjects in the study.
Case reports of the individuals from family 42 and 277 inheriting mutations in RPL10 The German family 42 comprised dizygotic twin brothers who were born to healthy, unrelated parents, who did not show any obvious autistic symptoms. The pregnancy of the then 31-year-old mother was threatened by abortion with intermittent bleeding between 14th and 20th week. Birth followed at 31st week gestation through cesarean section. The twins have been 8 years old at time of assessment. The first born twin had a birth weight of 1400 g. Cerebral ultrasound demonstrated an intraventricular hemorrhage in the right parietal lobe. Left-side hemiplegia was noted at an age of 1 year, shortly after a seizure disorder had become evident. The seizure was controlled through medication (Rivotril) for 3 years. His early childhood development was delayed. At the time of assessment he was not able to speak any words, was overactive and showed autoaggressive behavior. Both codings of the ADI-R and ADOS performed full criteria for autistic disorder. The IQ was estimated to be between 20 and 34 according to his clinical abilities and the Vineland Scales. 22, 23 Neurological examination showed a left sided hemiparesis. The CCT revealed a chicken eye big porus at the frontal lobe region, medium-to-higher grade dilation of the right and low-to-medium sized dilation of the left ventricle. The porus can be taken as a residuum of the perinatal hemorrhage. The second twin was born with a birth weight of 970 g. Cranial ultrasound was normal. First symptoms of developmental delay were noticed by the parents at an age of 12 months. Later on he developed stereotypic and repetitive manners. At an age of 7 years he was placed into a school for language delayed children due to his autistic behavior of delayed communication and social interaction albeit he did not show gross language delay. He received behavior therapy treatment and was on methylphenidate medication because of his severe hyperactivity. Upon clinical assessment he fulfilled all ADI-R and ADOS criteria for autistic disorder. His verbal and performance IQ were scored 82 and 80, respectively. The mother has eight more siblings (five female, three male). She reported that one nephew from her deceased sister is drug-addicted and has been diagnosed with schizophrenia. In addition, she reported that a brother of the maternal grandmother showed epileptic seizures, which have been interpreted within the family as 'Veitstanz' (Huntington disease). Unfortunately, it was not possible to receive blood samples from the extended family for the study.
The German family 277 comprised two brothers with autistic disorder (affected son 1 and affected son 2), age 5 and 3 years at the time of assessment. The children were born to unrelated healthy parents without obvious autistic symptoms, and had a 10-year-old half-brother (nonaffected son) from a second father. The affected son 1 was born after spontaneous labor with a birth weight of 2650 g. Early childhood development was normal but language delay was evident. He was only able to speak 20 words and no sentences at the age of 5 years. At 3.5 years he joined a special kindergarten and received ergotherapy and speech therapy. Within the ADI-R instrument he reached the cutoffs for social interaction and stereotype behavior, but missing the cutoff for communication and language for one item. The ADOS rating diagnosed autistic disorder. The IQ assessment was estimated to be between 50 and 69 according to his clinical abilities and the Vineland Scales. 22, 23 The younger brother (affected son 2) was diagnosed as having autism spectrum disorder at ADOS screening. He showed severe language delay. The ADI-R has thus far not been administered because of his age and language delay.
Genomic DNA and sequencing Blood DNA or DNA from lymphoblastoid cell lines of patients was extracted with standard methods. Exon sequences of the RPL10 gene including exon/intron boundaries and the U70 snoRNA (RNU70) were amplified by polymerase chain reaction (PCR) following standard protocols. Primer sequences and annealing temperatures are given in Table 1 . PCR fragments were sequenced using an ABI3100 automated sequencer using BigDye terminator cycle sequencing reagents (Applied Biosystems, Darmstadt, Germany). The protein alignment was performed with the Clustal program (HUSAR GCG software package, http://husar.dkfz-heidelberg.de/) using default settings. Sequences were retrieved from SwissProt/ TrEMBL (http://wwwexpasy.org/sprot/).
Yeast growth conditions, yeast strains and plasmids
Yeast media, culture conditions and the manipulation of yeast strains were as described in Rose et al. 24 Yeast cells were either incubated in rich medium (YPD) or synthetic medium (SC -URA), with the appropriate nutrient supplements. Yeast strain LK41-2B harbors the temperature-sensitive (ts) RPL10[G161D] mutation, originally called grc5-1 ts (growth control) 25 and yeast strains LK41-22C and YLG 499 (EUROSCARF strain BY4742a, EUROSCARF: http://www.uni-frankfurt.de/fb15/mikro/euroscarf) served as wild-type (WT) controls. The plasmids used in this study are listed in Table 2 and the yeast strains employed in this study are listed in Table 3 .
Plasmid pLM084 is a yeast/Escherichia coli shuttle vector YEplac195 26 derivative and harbors the human RPL10 gene, RGS-6His-tagged at the C-terminus and flanked by 500 bp promoter and 500 bp RPL10 terminator sequences from Saccharomyces cerevisiae (accession no. X78887). The human RPL10 gene was amplified by reverse transcription from total RNA. For first strand synthesis we used 1 mg of DNAse (Sigma AMP-D1, Taufkirchen, Germany) treated total RNA from human skin tissue (kindly supplied by Dr Kamil Oender, General Hospital, Salzburg, Austria). Synthesis was performed by reverse transcrip- 30 Thus, all cells were taken from an overnight culture (SC-URA or YPD), inoculated in fresh YPD medium and grown at 241C. This allows direct comparison of WT, mutant and transformed strains. Care was taken to harvest all cultures at exactly OD 600 0.7, that is, at exponential growth. Cells were incubated with cycloheximide (120 mg/ml culture) and were grown for an additional 15 min. All fractionation steps were performed at 41C. After chilling on ice for 15 min, cells were collected by centrifugation and the pellets were washed twice with TMNSH buffer (10 mM Tris HCl 50 mM NH 4 Cl 10 mM MgCl 2 12.5 mM 2-mercaptoethanol pH 7.4) and resuspended in lysis buffer (200 mM KCl, 1 mM phenylmethylsulfonyl fluorid, 120 mg/ml cycloheximide in TMNSH), using 5 ml/g wet weight. Following the addition of 1 volume (pellet) of 0.45 mm acidwashed glass beads, cells were lysed by 8 Â 30 s cycles of vortexing with 15 s on ice between each cycle. The lysates were cleared of cell debris by centrifugation at 6000 r.p.m. for 10 min in a Heraeus Megafuge 1.0R (6200 g). The supernatant was transferred into Eppendorf tubes and after addition of 1% Triton X-100 it was centrifuged at 15 000 r.p.m. for 10 min using a Beckman Avanti 30 Centrifuge F2402 rotor (20 000 g). Aliquots of 20 A 260 units were loaded on 11 ml of 7-47% sucrose gradients prepared in lysis buffer (lacking phenylmethylsulphonyl fluoride (PMSF), cycloheximide and 2-mercaptoethanol) and 
Results
Mutation screening of the ribosomal protein gene RPL10 in patients with autistic disorder The total sample of 345 patients suffering from autistic disorder (268 males and 77 females) was screened for mutations in RPL10. We identified two different missense mutations in exon 7 at the C-terminal end of the gene, which were present in two independent families, respectively (Figure 1a) . The two affected dizygotic twin brothers of family 42 had a C-A transversion at nucleotide (nt) 616 (NM_006013; the first base of the start codon counted as nt1) changing a highly conserved leucine residue to methionine (L206M) (human RPL10 protein, accession no. NP_006004). This allele was inherited from the heterozygotic and healthy mother. A C-G transversion at nt639 was identified in both affected Figure 1 Mutations in RPL10 in patients with autism. (a) Two missense mutations in exon 7 of RPL10 were found in two independent families. Pedigree structures and sequence chromatograms are shown for all available family members. Family 42 segregates for a missense mutation changing the predicted aa at position 206 from leucine to methionine (c.616C > A; L206M). Both autistic sons harbor the mutation that was inherited from the heterozygous mother. Family 277 includes two sons diagnosed with autistic disorder and severe language delay, who both carry a cytosine to guanine substitution (c.639C > G) resulting in an aa change from histidine to glutamine (H213Q). The mutation was not found in the healthy half-brother. Circle, female; square, male; circle with dot, carrier. males of a sib-pair in family 277, and causes an amino acid (aa) change from histidine to glutamine (H213Q) close to the L206M mutation (Figure 1b) . The mutated allele was not transmitted to the healthy half-brother. None of the two mutations was found in 408 control chromosomes. Next, genotypes of the previously described cSNP rs4909 (rs12012747) (G-A, nt605, aa S202N; Figure 1b) close to the mutations identified were evaluated for a possible disease association. However, patient and control samples showed almost identical distributions of genotype and allele frequencies for rs4909 ( Table 4 ), demonstrating that the patient sample under investigation exhibited no association with this specific single-nucleotide polymorphisms (SNP). Clearly, very rare mutation events in a disease gene of a complex disorder as in our cases are not expected to be reflected by positive association findings from a nearby SNP in a larger set of patients. Four other known nonsynonymous cSNPs in the N-terminal region of RPL10 did not show allelic variation in the patient sample under study. Other intronic SNPs have been identified in single cases only. Furthermore, the snoRNA U70 (RNU70) is located in intron 5 of RPL10 and coexpressed as one transcriptional unit with RPL10. We therefore screened the complete patient sample also for mutations in the U70 sequence but did not detect any base exchanges.
Functional analysis of the RPL10 mutations identified in autistic patients in a ts yeast strain To test for functionality and a potential modulating effect of the human RPL10 mutations, we first showed that the ts growth defect of yeast RPL10 Secondly, translation influenced by the human mutant RPL10 alleles has been studied in more detail by ribosomal profile analysis (Figure 3 ). Ribosomal Figure 3a and b) . WT yeast RPL10 and human RPL10 are able to complement the ts mutant phenotype of RPL10[G161D] yeast cells in that they increase the translating ribosome population and decrease the amount of free subunits (Figure 3c  and d) . Notably, this is a qualitative assessment, as restoration of a yeast mutant profile by ectopic expression of either the yeast or human WT activities do not result in a tracing completely identical to a yeast WT profile due to the formation of hybrid 60S subunits. 32, 33 Ectopic expression of mutant human RPL10
[L206M] and RPL10[H213Q] results in distinct ribosomal profiles (Figure 3e and f) : a small polysome population, a very large 80S population and an increase in the free 60S and 40S subunit populations, the latter merging with the top of the gradient. A similar phenotype has been observed in stationary phase cells ( 34 and our own unpublished observations). Thus, generation of a complete translating ribosome complement, that is, the polysome population, rather than basic translation per se is impaired in these cells. By Western blot analysis we detect RPL10-immunoreactive bands for RPL10[L206M] and RPL10[H213Q] in ribosomal fractions of transformed RPL10[G161D] cells (Figure 3e and f) . Their distribution in the profile fractions is identical to that observed for ectopically expressed yeast RPL10 and human WT RPL10 (Figure 3c and d) . These fractions represent polysomes, 80S monosomes and free 60S subunits, as expected for a bona fide ribosomal protein of the large 60S subunit. This proves that the mutant RPL10 proteins, like WT RPL10 proteins, are still associated with cytoplasmic ribosomes, while probably impairing control of distinct translation processes and/or the ribosome biogenesis pathway.
Discussion
The main approaches worldwide to identify susceptibility genes for autistic disorder are whole-genome linkage and gene association studies, respectively, followed by selective candidate gene analyses. So far, several susceptibility loci have been identified and more than a hundred candidate genes have been investigated without conclusive evidence for involvement in autistic disorder. 2 Here, we show results of a specific candidate gene screening in Xq28, a region recently presented with positive linkage results.
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Two missense mutations have been identified in the ribosomal protein L10 in two independent families with children affected by autistic disorder. Interestingly, both mutations found are located in the Cterminal domain of RPL10 that is encoded by exon 7 representing aa 165-214. This domain is found in eukaryota only, but not in prokaryota, and therefore of possible functional relevance for the eukaryotic ribosomal complex. 35 This sequence tract shows lower sequence conservation compared to the rest of the protein (Figure 4) . The aa exchange L206M (substitution score: þ 2 (BLOSUM62), þ 4 (PAM250)) affects the last aa in RPL10 that is almost completely conserved throughout the whole eukaryotic tree (Figures 1b and 4) . The second substitution H213Q (substitution score: 0 (BLOSUM62), þ 3 (PAM250)) is located at the extreme C-terminal end, which is conserved only in vertebrates. Although these data analyses do not suggest a change in the overall structure of RPL10 that would be imposed by these mutations, one may speculate that they have modulating effects on protein activity and/or structural stability within the ribosomal complex. To our knowledge, mutations in the only other at present identified ribosomal disease gene RPS19 cause a severe phenotype of erythroblastopenia associated with a variety of physical anomalies in up to 25% of patients suffering from DiamondBlackfan anemia. 36 These symptoms are the result of different mutations with devastating effects on the RPS19 protein structure. Diamond-Blackfan anemia presents as a potentially monogenic disorder with genetic heterogeneity, whereas autism is clearly a polygenic disorder with genetic heterogeneity as well. The mutations within RPL10 in the cases of autism described here may generate a functionally altered RPL10 protein and are potentially causative for cognitive malfunction, acting together with so far other unknown gene mutations or variations in the same individuals.
To follow up on the hypothesis of a functional and potential modulating effect of the two RPL10 mutations, both have been introduced into a yeast in vitro system. Comparative ribosomal profile analyses of ts mutant yeast RPL10 cells harboring human WT and mutant RPL10, respectively, suggest reduced functional complementation of the translationally active ribosomal fractions, that is, the polysomes, by the two human mutant alleles. Induction of dominantnegative C-terminal deletions of yeast RPL10 in WT yeast cells have been reported to result in ribosomal profiles reminiscent of those obtained from expression of human RPL10[L206M] and RPL10[H213Q] in the ts mutant yeast RPL10 cells here, that is, a relative reduction in the polysome complement and a concomitant increase in the 80S, 60S and 40S peaks. 35 At present we cannot say, whether the yeast C-terminal dominant-negative deletions and the C-terminal human mutations impact on the same RPL10 mediated function in reduction of translational activity. Clearly, expression of the yeast C-terminal deletions and the human C-terminal mutant alleles generate a distinct ribosomal profile phenotype, which is also reported for yeast stationary phase cells, that is, cells with a reduced translational activity. 34 Collectively, these observations indicate that the human mutant alleles RPL10[L206M] and RPL10[H213Q] found in autism patients may be functional hypomorphs in that they support growth of RPL10[G161D] cells at the restrictive temperature, possibly by supplying basic translation functions missing in these yeast ts mutant cells. 16 However, the distinct qualitative modifications in the RPL10[G161D] ribosomal profile induced by expression of human mutant alleles, but not by expression of the human WT ortholog (compare Figure 3b , e and f), is compatible with the hypothesis, that the human mutant RPL10 proteins may exhibit altered functions in the regulation and modulation of the actively transcribing ribosome complement. This might compromise the timely translation of mRNAs into polypeptide chains in general. Alternatively, the translation of transcripts of some specific genes might be perturbed.
The detection of mutations with a potential modulating effect in the RPL10 gene in patients suffering from autistic disorder in this study and findings from previous studies lead us to summarize four lines of evidence in a model explaining in part the developmental impairments in autism which are mediated through the hippocampus ( Figure 5 ).
(i) We previously observed high-level expression of RPL10 in mouse hippocampus, 12 the site of action for learning, memory and social and affective functions, all of which are impaired in autism. Several histopathological studies on post-mortem brain sections and magnetic resonance imaging (MRI) studies have shown involvement of the limbic system, especially the hippocampus, in autism. 35 Disease-specific patterns of small, closely packed neurons with limited dendritic arbors have been noticed in hippocampus and amygdala, which resemble features of an immature brain as well as a decreased measure of the hippocampal complex. 4, 37, 38 (ii) Plasticity of synaptic strength is mandatory for successful long-term storage of information in the neuronal hippocampal network. 39, 40 Synaptic plasticity is formed by building or erasing dendritic spines. Formation of interneuronal connections is dependent on new protein synthesis within the dendrites of cortical neurons, 40, 41 which is not coupled to new RNA transcription Figure 4 Alignment of RPL10e/RPL16 protein sequences. Sequences are abbreviated as follows: hs Homo sapiens (RL10_HUMAN); bt Bos taurus (RL10_BOVIN); mm Mus musculus (RL10_MOUSE); gg Gallus gallus (RL10_CHICK, corrected with EST and genomic data); xl Xenopus laevis (Q7ZXK4_XENLA); dr Danio rerio (Q7ZV96_BRARE); pm Petromyzon marinus (Q801H9_PETMA); bb Branchiostoma belcheri (Q86QS5_BRABE); dm Drosophila melanogaster (RL10_DROME); ce Caenorhabditis elegans (RL10_CAEEL); ha Hydra attenuate (Q6LCG6_HYDAT); sc Saccharomyces cerevisiae (Eukaryota, Fungi; RL10_YEAST); eg Euglena gracilis (Eukaryota, Euglenozoa; RL10_EUGGR); pf Plasmodium falciparum (Eukaryota, Alveolata; Q8ILV2_PLAF7); at Arabidopsis thaliana (Eukaryota, Viridiplantae, RL10_ARATH); af Archaeoglobus fulgidus (Archaea; RL10_ARCFU); bs Bacillus subtilis (Eubacteria; RL16_BACSU). Exon 7 is representing the C-terminal domain spanning aa 165-214 of human RPL10. Blue arrow: position of the human cSNP rs4909 (S202N) ; the human reference sequence shows the minor allele aa N202. Red arrows: aa 206 and 213 changed through mutations (L206M and H213Q) in the two different families with autism, respectively. The figure display is shown with clustalW colors. but makes use of already formed ribosomal complexes. Disturbance of factors in this process, which is activated through ionotropic and metabotropic glutamate receptors at the postsynaptic membrane and different intracellular signaling pathway components, has been found responsible for genetic disorders with cognitive malfunction. For example, the human fragile X mental retardation syndrome is caused by loss of the FMRP protein. The disorders of fragile X and autism have overlapping symptomatologies. Lack of FMRP increases long-term depression in mouse hippocampus, because the function of FMRP as translational repressor affecting specific mRNAs pools is abrogated. 41, 42 Prolonged protein synthesis is induced at the dendritic spine and finally leads to loss of synaptic connections. Hence, it is conceivable that the mutated RPL10 within the ribosomal complex, like FMRP, disturbs the balance of translation, but this needs further analysis following up on the initiated functional yeast cell assays shown here. We and others have reported that secretory pathway activity in yeast, needed for growth of the cell surface, is coregulated by and linked to ribosome function, involving yeast RPL10 and other ribosomal proteins. 30, 43, 44 Thus, malfunction of human RPL10 may impact on the timely translation of cell surface components. A consequence might be the loss of dendritic arbors of pyramidal neurons 4 causing underconnectivity 45 during the brain developmental process which could lead to autistic disorder. Recently, the theory of connectivity problems in autistic brains has been sustained by several studies using functional MRI and PET analyses. 46 (iii) Neuroligin is anchored in the postsynaptic membrane connected to its presynaptic ligand neurexin and acts in concert with other proteins to recruit synapse-dendrite connections in the same pathway of synaptogenesis. Mutations in the neuroligin genes NLGN4 and NLGN3, also located on the X chromosome, have been detected recently in a few cases of autistic disorder or XLMR with and without autistic disorder, respectively. 47, 48 It remains to be elucidated whether such rare cases of autism have common genetic causes with some forms of mental retardation. (iv) Interneurons in the CA3 region of the hippocampal complex play a significant role in controlling hippocampal neuronal excitability by interaction 4 The neurotransmitter serotonin is involved in neuronal excitability of interneurons in hippocampus with influence on dendritic atrophy. 39 Serotonin levels are increased (red arrow) in a subset of autistic patients. 1, 50 (c) Histopathological studies on post-mortem brain sections of patients with autism showed decreased overall measure of hippocampus and small, closely packed neurons. 37, 38 Blue arrows indicate the neuronal signal circuitry pathway through the hippocampus via pyramidal neurons from the dentate gyrus to the CA3 and CA1 regions and finally back to the entorhinal cortex. Round black arrows denote consequences of impairments on the cellular level for morphology of pyramidal neurons and further the hippocampal brain structure in autistic disorder.
of neurons and neurotransmitters. Serotonin, for example, is responsible for dendritic atrophy upon reduced reuptake through the serotonin transporter (5-HTT). 37 Association of 5-HTT with autism has been revealed in several but not all study groups worldwide. 19, 49, 50 In conclusion, it is intriguing that several rare cases of autism present with mutations in genes, all of which are hypothesized to modulate synaptic plasticity in the hippocampus. It remains to be elucidated if these and other genetic factors are contributing -via this or other pathways -to the development of aberrant neural central nervous system connections noticed in autism. In the future, we will explore in more detail in different mouse models, the structural and developmental impairments of potentially modulating mutations in the otherwise evolutionary highly conserved ribosomal protein RPL10. This will allow us to gain further functional insights into the complex disorder of autism.
